Isabella Baglioni1, Alessia Galli2, Chiara Gatti3, Simona Tufoni4, Renato Rocchi5, Federico Lattanzi6, Fabio Toia7, Adoriano Santarelli8, Stefano Marcelli8
1Clinical Tutor – Bachelor’s deegre in Nursing, ASUR Marche Area Vasta N.4,
2Emergency Room, Department of Emergency Medicine, Azienda OspedalieraUniversitaria Ospedali Riuniti, Ancona, Italy,
3Paediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care, Department of Cardiovascular Sciences, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy,
4Clinical Tutor- Bachelor’s deegre in Nursing, ASUR Marche Area Vasta N.4,
5Director of the Complex Operative Unit of the Health Professions Service – ASUR Marche Area Vasta N.4, 6Clinical Nurse, – Potes 118 (Fixed Station of First Territorial Relief), ASUR Marche Area Vasta N.4,
7Emergency Room, Department of Emergency Medicine, – ASUR Marche Area Vasta N.3,
8Director of Professional Teaching Activities – Bachelor’s deegre in Nursing, ASUR Marche Area Vasta N.5
Keywords: COVID-19, vaccine, antibody, Adverse Drug Event
ABSTRACT
Background.